{"id":"W2856119501","doi":"10.1016/j.msard.2018.07.012","title":"Use of the new oral disease-modifying therapies for multiple sclerosis in British Columbia, Canada: the first five-years","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba; University of British Columbia","funders":"","keywords":"Teriflunomide; Fingolimod; Medicine; Multiple sclerosis; Glatiramer acetate; Natalizumab; Medical prescription; Poisson regression; Internal medicine; Pediatrics; Pharmacology; Environmental health; Population; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00229045,0.0005267858,0.001112435,0.002151115,0.003466893,0.002995074,0.002203032,0.001720921,0.001896256],"category_scores_gemma":[0.007335548,0.0005140773,0.001159075,0.006239653,0.001013585,0.001339478,0.001722602,0.003052601,0.0002692365],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.04662712,"about_ca_system_score_gemma":0.08507087,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9957623,"about_ca_topic_score_gemma":0.9973116,"domain_scores_codex":[0.9969758,0.0002559484,0.0002857512,0.0002306949,0.001351025,0.0009007736],"domain_scores_gemma":[0.989734,0.000544639,0.001726964,0.000180569,0.005864852,0.001949046],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007433182,0.0002637706,0.9540765,0.0005432342,0.0003284272,0.0003111741,0.002648677,0.0001997113,0.0002912524,0.0004162905,0.005268895,0.03490882],"study_design_scores_gemma":[0.00002777139,0.0001139933,0.9904242,0.0003534773,0.0001988693,0.0001130663,0.003027527,0.0001987216,0.000102201,0.00005115292,0.005350614,0.00003848021],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9260795,0.04333953,0.000235812,0.006625928,0.000261567,0.0001827665,0.01291097,0.00004723049,0.01031677],"genre_scores_gemma":[0.9719121,0.0166551,0.0003994421,0.001106539,0.00006272562,0.00006355586,0.004322631,0.00001501349,0.005463052],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04662712,"threshold_uncertainty_score":0.338305,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0565569203432232,"score_gpt":0.2497794622588133,"score_spread":0.1932225419155901,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}